{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:23:26Z","timestamp":1761578606351,"version":"3.41.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1097\/md.0000000000004382","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T20:06:24Z","timestamp":1470859584000},"page":"e4382","source":"Crossref","is-referenced-by-count":7,"title":["A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation"],"prefix":"10.1097","volume":"95","author":[{"given":"Zhonghai","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-34-20210226","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.CIR.0000036744.39782.9F","article-title":"Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation","volume":"106","author":"Jais","year":"2002","journal-title":"Circulation"},{"key":"R2-34-20210226","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.106.633735","article-title":"Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism","volume":"114","author":"Atienza","year":"2006","journal-title":"Circulation"},{"key":"R3-34-20210226","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2217\/pgs.15.117","article-title":"Marfella R. microRNA expression changes after atrial fibrillation catheter ablation","volume":"16","author":"Sardu","year":"2015","journal-title":"Pharmacogenomics"},{"key":"R4-34-20210226","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"R5-34-20210226","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1172\/JCI84937","article-title":"Calcium release channel RyR2 regulates insulin release and glucose homeostasis","volume":"125","author":"Santulli","year":"2015","journal-title":"J Clin Invest"},{"key":"R6-34-20210226","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"R7-34-20210226","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2013.02.091","article-title":"Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients","volume":"62","author":"Marfella","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R8-34-20210226","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdiacomp.2014.09.002","article-title":"Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes","volume":"29","author":"Rizzo","year":"2015","journal-title":"J Diabetes Complications"},{"key":"R9-34-20210226","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"R10-34-20210226","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"R11-34-20210226","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"R12-34-20210226","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"R13-34-20210226","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"key":"R14-34-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R15-34-20210226","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"R16-34-20210226","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R17-34-20210226","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R18-34-20210226","first-page":"123","article-title":"Transcatheter left atrial appendage closure in patients with atrial fibrillation","volume":"16","author":"Schmid","year":"2013","journal-title":"Kardiovaskulare Medizin"},{"key":"R19-34-20210226","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jjcc.2013.02.019","article-title":"Left atrial appendage occlusion: single center experience with PLAATO LAA Occlusion System and AMPLATZER Cardiac Plug","volume":"62","author":"Helsen","year":"2013","journal-title":"J Cardiol"},{"key":"R20-34-20210226","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00392-015-0828-1","article-title":"Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation","volume":"104","author":"Gloekler","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"R21-34-20210226","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.hrthm.2013.08.025","article-title":"Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience","volume":"10","author":"Chun","year":"2013","journal-title":"Heart Rhythm"},{"key":"R22-34-20210226","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1253\/circj.CJ-13-0828","article-title":"Interventional closure of the left atrial appendage for stroke prevention","volume":"78","author":"Matsuo","year":"2014","journal-title":"Circ J"},{"key":"R23-34-20210226","first-page":"A4879","article-title":"Percutaneous left atrial appendage closure for stroke prevention","volume":"61","author":"De Backer","year":"2014","journal-title":"Dan Med J"},{"key":"R24-34-20210226","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ccd.24872","article-title":"Amplatzer left atrial appendage occlusion: single center 10-year experience","volume":"82","author":"Nietlispach","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"R25-34-20210226","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/01.CIR.0000015698.54752.6D","article-title":"Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience","volume":"105","author":"Sievert","year":"2002","journal-title":"Circulation"},{"key":"R26-34-20210226","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ccd.10660","article-title":"Transcatheter left atrial appendage occlusion with amplatzer devices to obviate anticoagulation in patients with atrial fibrillation","volume":"60","author":"Meier","year":"2003","journal-title":"Catheter Cardio Inte"},{"key":"R27-34-20210226","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1046\/j.1540-8167.14.s9.11.x","article-title":"Mechanical occlusion of the left atrial appendage","volume":"14","author":"Omran","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R28-34-20210226","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jacc.2005.03.042","article-title":"Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials","volume":"46","author":"Ostermayer","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R29-34-20210226","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jacc.2007.02.035","article-title":"Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation","volume":"49","author":"Sick","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R30-34-20210226","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jcin.2009.05.005","article-title":"Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study","volume":"2","author":"Block","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"R31-34-20210226","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ccd.22099","article-title":"Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation","volume":"74","author":"Ussia","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"R32-34-20210226","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4244\/EIJV6I2A35","article-title":"PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study","volume":"6","author":"Bayard","year":"2010","journal-title":"Eurointervention"},{"key":"R33-34-20210226","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ccd.22764","article-title":"Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience","volume":"77","author":"Park","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"R34-34-20210226","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3349\/ymj.2012.53.1.83","article-title":"Early experience using a left atrial appendage occlusion device in patients with atrial fibrillation","volume":"53","author":"Kim","year":"2012","journal-title":"Yonsei Med J"},{"key":"R35-34-20210226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0066-782X2012005000012","article-title":"Percutaneous occlusion of left atrial appendage with the Amplatzer Cardiac PlugTM in atrial fibrillation","volume":"98","author":"Montenegro","year":"2012","journal-title":"ARQ Bras Cardiol"},{"key":"R36-34-20210226","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ccd.23136","article-title":"Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience","volume":"79","author":"Lam","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"R38-34-20210226","first-page":"528","article-title":"Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation","volume":"98","author":"Guerios","year":"2012","journal-title":"ARQ Bras Cardiol"},{"key":"R39-34-20210226","first-page":"8","article-title":"Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility","volume":"71","author":"Streb","year":"2013","journal-title":"Kardiol Pol"},{"key":"R40-34-20210226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/pace.12058","article-title":"Does left atrial appendage closure with a cardiac plug system reduce the stroke risk in nonvalvular atrial fibrillation patients? A single-center case series","volume":"36","author":"Danna","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"R41-34-20210226","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R42-34-20210226","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jacc.2013.02.089","article-title":"Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy","volume":"62","author":"Urena","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R43-34-20210226","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/AC.68.6.8000001","article-title":"Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry","volume":"68","author":"Kefer","year":"2013","journal-title":"Acta Cardiol"},{"key":"R44-34-20210226","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5830\/CVJA-2013-018","article-title":"Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience","volume":"24","author":"Abelson","year":"2013","journal-title":"Cardiovasc J AFR"},{"key":"R45-34-20210226","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4244\/EIJV9I4A75","article-title":"New technical and anticoagulation aspects for left atrial appendage closure using the WATCHMAN\u00ae device in patients not taking warfarin","volume":"9","author":"Meincke","year":"2013","journal-title":"Eurointervention"},{"key":"R46-34-20210226","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.ijcard.2013.06.062","article-title":"Early safety of the Amplatzer Cardiac Plug for left atrial appendage occlusion","volume":"168","author":"Meerkin","year":"2013","journal-title":"Int J Cardiol"},{"key":"R47-34-20210226","first-page":"90","article-title":"Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer cardiac plug","volume":"66","author":"Lopez-Minguez","year":"2013","journal-title":"Rev Esp Cardiol (Engl Ed"},{"key":"R48-34-20210226","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1212\/WNL.0000000000000022","article-title":"Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage","volume":"82","author":"Horstmann","year":"2014","journal-title":"Neurology"},{"key":"R49-34-20210226","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijcard.2014.03.154","article-title":"Left atrial appendage occlusion: initial experience with the Amplatzer Amulet","volume":"174","author":"Freixa","year":"2014","journal-title":"Int J Cardiol"},{"key":"R50-34-20210226","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ccd.25354","article-title":"Amplatzer left atrial appendage occlusion through a patent foramen ovale","volume":"84","author":"Koermendy","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"R51-34-20210226","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ccd.25329","article-title":"Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation","volume":"83","author":"Wiebe","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"R52-34-20210226","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ccd.25644","article-title":"Left atrial appendage closure using the Amulet device: an initial experience with the second generation amplatzer cardiac plug","volume":"85","author":"Lam","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"R53-34-20210226","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/heartjnl-2014-306332","article-title":"Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure","volume":"101","author":"Minguez","year":"2015","journal-title":"Heart"},{"key":"R54-34-20210226","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"R55-34-20210226","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation\u2014developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"R56-34-20210226","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/STROKEAHA.110.590257","article-title":"Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort","volume":"41","author":"Lip","year":"2010","journal-title":"Stroke"},{"key":"R57-34-20210226","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"R58-34-20210226","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.jacc.2014.02.549","article-title":"Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes","volume":"63","author":"Hylek","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R59-34-20210226","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/eurheartj\/ehr393","article-title":"Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation","volume":"33","author":"Landmesser","year":"2012","journal-title":"Eur Heart J"},{"key":"R60-34-20210226","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","article-title":"The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy","volume":"59","author":"Viles-Gonzalez","year":"2012","journal-title":"J Am Coll Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:00:10Z","timestamp":1749056410000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201608020-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":59,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004382","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}